Jefferies Maintains Hold on Moderna, Lowers Price Target to $55

Benzinga · 10/15 16:57
Jefferies analyst Michael Yee maintains Moderna (NASDAQ:MRNA) with a Hold and lowers the price target from $65 to $55.